documents: FDA-2007-D-0369-0328
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2007-D-0369-0328 | FDA | FDA-2007-D-0369 | Federal Register Notice Draft Guidance for Industry on Bioequivalence Recommendations for Sucroferric Oxyhydroxide 80 Fed. Reg. 12,503 re Comment from Vifor Pharma, Ltd | Supporting & Related Material | Background Material | 2015-05-13T04:00:00Z | 2015 | 5 | 2015-05-13T14:12:31Z | 0 | 0 | 0900006481addb43 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref